In addition, transcriptional signatures have been generated that distinguish BRCA1/2-associated and sporadic ovarian or breast cancer and may be able to recognize tumors with HR deficiency, BRCAness phenotype and/or PARP sensitivity [105,106,107,108]. The gene discussed is PARP1; the disease is breast carcinoma.